Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-026509
Filing Date
2022-09-21
Accepted
2022-09-21 18:27:51
Documents
1
Period of Report
2022-09-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4006
  Complete submission text file 0001493152-22-026509.txt   5644
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
THERALINK TECHNOLOGIES, INC. (Issuer) CIK: 0001362703 (see all company filings)

EIN.: 202590810 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1601 BLAKE ST. SUITE 310 DENVER CO 80202
Business Address
Busch Jeffrey (Reporting) CIK: 0001620772 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52218 | Film No.: 221257569